This brief communication describes the case of a patient with colorectal cancer with a TP53 germline mutation initially considered somatic because no TP53 germline mutation was noted in the liquid biopsy (cell-free DNA) next-generation sequencing assay.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Sorscher, S., Desnoyers, R., Ouyang, K., & Ramkissoon, S. (2017). Li-Fraumeni versus Pseudo-Li-Fraumeni Syndrome: Key Insights for Interpreting Next-Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes. The Oncologist, 22(9), 1084–1085. https://doi.org/10.1634/theoncologist.2017-0016